Any medical decision regarding overweight, obesity, or diabetes should be made through a medical consultation within a coordinated care pathway
In September 2023, FDA placed "Thymosin Beta-4, Fragment (LKKTETQ)," the substance sold as TB-500, on Category 2 of its interim 503A bulk drug substances list, meaning FDA identified significant safety concerns and would not permit licensed compounding pharmacies to use it
Lamhamedi-Cherradi SE, Menegaz BA, Ramamoorthy V, Vishwamitra D, Wang Y, Maywald RL, et al
T.BeckT.BennettD
Based on previous reports that point to a correlation between amphipathicity and antimicrobial activity [112], a slightly modified eCATH-3 peptide was synthesized (LLK-eCATH-3) with a higher hydrophobic moment and helical content realized by the substitution of three amino-acid residues
The researchers stressed that PAT is not a replacement for established depression treatments and that more evidence is needed